Related Articles
Dihydroartemisinin-induced apoptosis in human acute monocytic leukemia cells
Dihydroartemisinin increases temozolomide efficacy in glioma cells by inducing autophagy
Dihydroartemisinin treatment of multiple myeloma cells causes activation of c-Jun leading to cell apoptosis
Dihydroartemisinin inhibits the Raf/ERK/MEK and PI3K/AKT pathways in glioma cells Corrigendum in /10.3892/ol.2021.12636
Dihydroartemisinin inhibits endothelial cell proliferation through the suppression of the ERK signaling pathway